AOM Infusion key facts
- Provider of home infusion and intravenous therapy services designed to support patients with chronic and acute medical conditions.
- It has raised $13.3M; the latest was Leveraged Recapitalization in Mar 2026.
- Notable investors include Revelstoke Capital Partners, Ridgemont Equity Partners.
- Status: Privately Held (backing).
Who backs AOM Infusion
2- ·Watch AOM Infusion: the Monday email on marks, rounds and moves
AOM Infusion funding rounds
No funding rounds for AOM Infusion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AOM Infusion investors
2 investors are on record for AOM Infusion, including Revelstoke Capital Partners and Ridgemont Equity Partners.
About AOM Infusion
Provider of home infusion and intravenous therapy services designed to support patients with chronic and acute medical conditions. The company offers IVIG therapy, pharmacy support, referral coordination, insurance assistance, skilled nursing care, and patient education, enabling individuals, families, and healthcare professionals to access efficient, cost-effective treatment in the comfort of their home.
- Sector
- Healthcare
- HQ
- Fort Worth, TX, United States
- Founded
- 1994
- Employees
- 141
- Website
- americanoutcomes.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
AOM Infusion doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.